Abundance of intrinsic disorder in protein associated with cardiovascular disease

被引:155
作者
Cheng, Yugong
LeGall, Tanguy
Oldfield, Christopher J.
Dunker, A. Keith
Uversky, Vladimir N.
机构
[1] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA
[2] Mol Kinet Inc, Indianapolis, IN 46268 USA
[3] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Moscow, Russia
关键词
D O I
10.1021/bi060981d
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Evidence that many protein regions and even entire proteins lacking stable tertiary and/or secondary structure in solution (i.e., intrinsically disordered proteins) might be involved in protein-protein interactions, regulation, recognition, and signal transduction is rapidly accumulating. These signaling proteins play a crucial role in the development of several pathological conditions, including cancer. To test a hypothesis that intrinsic disorder is also abundant in cardiovascular disease (CVD), a data set of 487 CVD-related proteins was extracted from SWISS-PROT. CVD-related proteins are depleted in major order-promoting residues (Trp, Phe, Tyr, Ile, and Val) and enriched in some disorder-promoting residues (Arg, Gln, Ser, Pro, and Glu). The application of a neural network predictor of natural disordered regions (PONDR VL-XT) together with cumulative distribution function (CDF) analysis, charge-hydropathy plot (CH plot) analysis, and alpha-helical molecular recognition feature (alpha-MoRF) indicator revealed that CVD-related proteins are enriched in intrinsic disorder. In fact, the percentage of proteins with 30 or more consecutive residues predicted by PONDR VL-XT to be disordered was 57 +/- 4% for CVD-associated proteins. This value is close that described earlier for signaling proteins (66 +/- 6%) and is significantly larger than the content of intrinsic disorder in eukaryotic proteins from SWISS-PROT (47 +/- 4%) and in nonhomologous protein segments with a well-defined three-dimensional structure (13 +/- 4%). Furthermore, CDF and CH-plot analyses revealed that 120 and 36 CVD-related proteins, respectively, are wholly disordered. This high level of intrinsic disorder could be important for the function of CVD-related proteins and for the control and regulation of processes associated with cardiovascular disease. In agreement with this hypothesis, 198 R-MoRFs were predicted in 101 proteins from the CVD data set. A comparison of disorder predictions with the experimental structural and functional data for a subset of the CVD-associated proteins indicated good agreement between predictions and observations. Thus, our data suggest that intrinsically disordered proteins might play key roles in cardiovascular disease.
引用
收藏
页码:10448 / 10460
页数:13
相关论文
共 103 条
[1]   Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2 [J].
Adkins, JN ;
Lumb, KJ .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 2002, 46 (01) :1-7
[2]   Protein-protein interactions and cancer: small molecules going in for the kill [J].
Arkin, M .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2005, 9 (03) :317-324
[3]   Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream [J].
Arkin, MR ;
Wells, JA .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :301-317
[4]   ACTION OF THROMBIN IN THE CLOTTING OF FIBRINOGEN [J].
BAILEY, K ;
BETTELHEIM, FR ;
LORAND, L ;
MIDDLEBROOK, WR .
NATURE, 1951, 167 (4241) :233-234
[5]   Clusterin, a binding protein with a molten globule-like region [J].
Bailey, RW ;
Dunker, AK ;
Brown, CJ ;
Garner, EC ;
Griswold, MD .
BIOCHEMISTRY, 2001, 40 (39) :11828-11840
[6]   The unique N-terminal domain of the cAMP phosphodiesterase PDE4D4 allows for interaction with specific SH3 domains [J].
Beard, MB ;
O'Connell, JC ;
Bolger, GB ;
Houslay, MD .
FEBS LETTERS, 1999, 460 (01) :173-177
[7]   Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo [J].
Bottger, A ;
Bottger, V ;
Sparks, A ;
Liu, WL ;
Howard, SF ;
Lane, DP .
CURRENT BIOLOGY, 1997, 7 (11) :860-869
[8]   Theoretical analysis of alternative splice forms using computational methods [J].
Boué, S ;
Vingron, M ;
Kriventseva, E ;
Koch, I .
BIOINFORMATICS, 2002, 18 :S65-S73
[9]   The second Kunitz domain of human tissue factor pathway inhibitor: Cloning, structure determination and interaction with Factor Xa [J].
Burgering, MJM ;
Orbons, LPM ;
vanderDoelen, A ;
Mulders, J ;
Theunissen, HJM ;
Grootenhuis, PDJ ;
Bode, W ;
Huber, R ;
Stubbs, MT .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 269 (03) :395-407
[10]   Studies of the RNA degradosome-organizing domain of the Escherichia coli ribonuclease RNase E [J].
Callaghan, AJ ;
Aurikko, JP ;
IIag, LL ;
Grossmann, JG ;
Chandran, V ;
Kühnel, K ;
Poljak, L ;
Carpousis, AJ ;
Robinson, CV ;
Symmons, MF ;
Luisi, BF .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 340 (05) :965-979